[Tc-99m]-Sestamibi (2017-09-22)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: Healthcare Professionals, General Public, Hospitals
Department: Health Canada
Hazard classification: Type II
| Lot or serial number | Companies | Brand name | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| M-170830MIBI-1, M-170830MIBI-2, | - Recalling Firm
- Centre for Probe Development and Commercialization (CPDC)
- 1280 Main St. W. NRB-A316
- Hamilton
- L8S 4K1
- Ontario
- CANADA
- Marketing Authorization Holder
- Not Applicable
| [Tc-99m]-Sestamibi | Liquid | No market authorization | 5.59, 1.73, and 5.85 GBq |
Affected products
[Tc-99m]-Sestamibi
The sterility may be out of specification in the affected lots.
3 Hospitals located in Hamilton, Ontario, Canada